Interestingly, blocking the function of Ang2, impaired the interaction between ECs and immune cells and reduced tumor neovascularization (285), suggesting that Ang2 is one of the targets of the YAP/TAZ pathway that might be amenable to normalize the tumor vasculature. The gene discussed is YAP1; the disease is neoplasm.